Traws Pharma, Inc. (NASDAQ:TRAW) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Traws Pharma, Inc. Second Quarter 2025 Financial Results and Business Update Call.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 605,531 | $1,120,232 | 0.03% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 330,000 | $610,500 | 0% | |
| 3. | Vestal Point Capital Ryan Wilder | 150,000 | $277,500 | +1% | 0.01% |
| 4. | Ikarian Capital Neil Shahrestani | 28,493 | $52,712 | 0.01% | |
| 5. | Alyeska Investment Group Anand Parekh | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.67 | 1,500 | $2,505.00 | 24,514 | 2022-01-28 | Filing | |
| $2.02 | 1,500 | $3,030.00 | 23,014 | 2022-01-21 | Filing | |
| $2.20 | 1,500 | $3,300.00 | 21,514 | 2022-01-14 | Filing | |
| $2.39 | 1,500 | $3,585.00 | 20,014 | 2022-01-07 | Filing | |
| $3.16 | 1,000 | $3,160.00 | 18,514 | 2021-11-19 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.27 | 527,863 | $143,948.24 | 16,683 | 2020-08-27 | Filing | |
| $0.27 | 1,876 | $510.08 | 0 | 2020-08-27 | Filing | |
| $0.27 | 182,492 | $49,619.57 | 21,919 | 2020-08-27 | Filing | |
| $1.19 | 16,700 | $19,873.00 | 616,389 | 2019-09-24 | Filing | |
| $0.00 | 0 | $0.00 | 816,702 | 2019-09-23 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 87,259 | $161,429 | 0% | |
| 2. | 43,440 | $80,366 | 0% | |
| 3. | 22,018 | $40,733 | 0% | |
| 4. | 10,708 | $19,810 | 0% | |
| 5. | 9,956 | $18,419 | 0% |